1. Home
  2. LEGN vs DJT Comparison

LEGN vs DJT Comparison

Compare LEGN & DJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • DJT
  • Stock Information
  • Founded
  • LEGN 2014
  • DJT 2021
  • Country
  • LEGN United States
  • DJT United States
  • Employees
  • LEGN N/A
  • DJT N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • DJT Computer Software: Programming Data Processing
  • Sector
  • LEGN Health Care
  • DJT Technology
  • Exchange
  • LEGN Nasdaq
  • DJT Nasdaq
  • Market Cap
  • LEGN 7.8B
  • DJT 6.9B
  • IPO Year
  • LEGN 2020
  • DJT N/A
  • Fundamental
  • Price
  • LEGN $34.68
  • DJT $38.01
  • Analyst Decision
  • LEGN Strong Buy
  • DJT
  • Analyst Count
  • LEGN 13
  • DJT 0
  • Target Price
  • LEGN $81.54
  • DJT N/A
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • DJT 13.7M
  • Earning Date
  • LEGN 11-12-2024
  • DJT 02-03-2025
  • Dividend Yield
  • LEGN N/A
  • DJT N/A
  • EPS Growth
  • LEGN N/A
  • DJT N/A
  • EPS
  • LEGN N/A
  • DJT N/A
  • Revenue
  • LEGN $520,183,000.00
  • DJT $3,369,800.00
  • Revenue This Year
  • LEGN $120.77
  • DJT N/A
  • Revenue Next Year
  • LEGN $68.54
  • DJT N/A
  • P/E Ratio
  • LEGN N/A
  • DJT N/A
  • Revenue Growth
  • LEGN 122.96
  • DJT N/A
  • 52 Week Low
  • LEGN $32.66
  • DJT $11.75
  • 52 Week High
  • LEGN $70.13
  • DJT $79.38
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 32.71
  • DJT 61.61
  • Support Level
  • LEGN $40.97
  • DJT $32.71
  • Resistance Level
  • LEGN $43.96
  • DJT $37.61
  • Average True Range (ATR)
  • LEGN 2.03
  • DJT 2.15
  • MACD
  • LEGN -0.72
  • DJT 0.47
  • Stochastic Oscillator
  • LEGN 16.97
  • DJT 90.84

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About DJT Trump Media & Technology Group Corp. Common Stock

Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest global conversation without discriminating against political ideology.

Share on Social Networks: